Ubs Oconnor LLC Ardelyx, Inc. Transaction History
Ubs Oconnor LLC
- $1.46 Billion
- Q3 2024
A detailed history of Ubs Oconnor LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Ubs Oconnor LLC holds 60,736 shares of ARDX stock, worth $277,563. This represents 0.03% of its overall portfolio holdings.
Number of Shares
60,736Holding current value
$277,563% of portfolio
0.03%Shares
8 transactions
Others Institutions Holding ARDX
# of Institutions
218Shares Held
141MCall Options Held
1.02MPut Options Held
1.22M-
Janus Henderson Group PLC London, X021.5MShares$98.4 Million0.08% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$80.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.6MShares$62.1 Million0.0% of portfolio
-
State Street Corp Boston, MA12.1MShares$55.5 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C38.95MShares$40.9 Million0.07% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $707M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...